The Manila Times

Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Develop…

Dyadic Applied BioSolutions ('Dyadic”, 'we”, 'us”, 'our”, or the 'Company”) (NASDAQ: DYAI), a global biotechnology company ...

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q4 2025 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Nautilus Biotechnology Q4 2025 Earnings Conference Call.
Opinion
War on the RocksOpinion

All Too Quiet on the Western Neuroenhancement Front

A merry little surge of electricity piped by automatic alarm from the mood organ beside his bed awakened Rick Deckard.” The characters in Philip K.

The Startup Building An Operating System For Biotech AI

Building an AI infrastructure for biotech. Bacteria that munch on cancer. How to best make a cold brew. All that and more in ...

IGC Pharma, Inc.: IGC Pharma Files Utility Patent Applications Covering AI-Based Data Harmonization Architecture Supporting Alzheimer's Research

POTOMAC, MD / ACCESS Newswire / February 26, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a clinical-stage biotechnology company developing therapeutics for Alzheimer's diseas ...
The Manila Times

Serina Therapeutics Announces Dosing of First Patient in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s Disease

Blinded evaluation of safety and tolerability data by the Safety Monitoring Committee from Cohort 1 and advancement to Cohort 2 is expected in 3Q 2026 - ...